Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors

Documenti analoghi

• Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study
  di: Donders, Gilbert, et al.
  Pubblicazione: (2014)
• Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy
  di: Jaisamrarn, U., et al.
  Pubblicazione: (2013)
• Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review
  di: Ünlü, Cihat, et al.
  Pubblicazione: (2011)
• Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome
  di: Oerlemans, Eline F. M., et al.
  Pubblicazione: (2020)
• Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial
  di: Hirschberg, Angelica Lindén, et al.
  Pubblicazione: (2020)